PURPOSE: To report a case of unilateral late-presenting acute posterior multifocal placoid pigment epitheliopathy (APMPPE) with CME evaluated before and after administration of IVTA. METHOD: A 29-year-old male diagnosed as APMPPE with CME was treated with IVTA. RESULTS: Fundus examination revealed CME and sequelae APMPPE lesions without involvement of posterior pole. FA and OCT findings were consistent with CME. After IVTA (4 mg/0.1 mL) administration; BCVA increased from 20/28 to 20/20, mean retinal thickness decreased in OCT, and mean sensitivity in microperimetry increased from 15.7 to 17.2 dB. CONCLUSION: In this case report, IVTA improved macular anatomy, visual acuity, and macular sensitivity.
PURPOSE: To report a case of unilateral late-presenting acute posterior multifocal placoid pigment epitheliopathy (APMPPE) with CME evaluated before and after administration of IVTA. METHOD: A 29-year-old male diagnosed as APMPPE with CME was treated with IVTA. RESULTS: Fundus examination revealed CME and sequelae APMPPE lesions without involvement of posterior pole. FA and OCT findings were consistent with CME. After IVTA (4 mg/0.1 mL) administration; BCVA increased from 20/28 to 20/20, mean retinal thickness decreased in OCT, and mean sensitivity in microperimetry increased from 15.7 to 17.2 dB. CONCLUSION: In this case report, IVTA improved macular anatomy, visual acuity, and macular sensitivity.